Journey Strategic Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28M | Buy |
23,052
+6,856
| +42% | +$1.27M | 0.14% | 55 |
|
|
2025
Q1 | $3.39M | Buy |
16,196
+6,469
| +67% | +$1.36M | 0.12% | 55 |
|
|
2024
Q4 | $1.73M | Buy |
9,727
+2,671
| +38% | +$475K | 0.06% | 83 |
|
|
2024
Q3 | $1.39M | Buy |
7,056
+808
| +13% | +$160K | 0.05% | 99 |
|
|
2024
Q2 | $1.07M | Buy |
6,248
+165
| +3% | +$28.3K | 0.05% | 85 |
|
|
2024
Q1 | $1.11M | Buy |
6,083
+3,956
| +186% | +$720K | 0.05% | 72 |
|
|
2023
Q4 | $330K | Sell |
2,127
-39
| -2% | -$6.05K | 0.02% | 127 |
|
|
2023
Q3 | $323K | Sell |
2,166
-368
| -15% | -$54.9K | 0.02% | 110 |
|
|
2023
Q2 | $341K | Sell |
2,534
-2,341
| -48% | -$315K | 0.02% | 108 |
|
|
2023
Q1 | $777K | Sell |
4,875
-774
| -14% | -$123K | 0.08% | 71 |
|
|
2022
Q4 | $913K | Buy |
5,649
+852
| +18% | +$138K | 0.11% | 61 |
|
|
2022
Q3 | $644K | Buy |
4,797
+1,718
| +56% | +$231K | 0.09% | 55 |
|
|
2022
Q2 | $472K | Sell |
3,079
-1,178
| -28% | -$181K | 0.06% | 61 |
|
|
2022
Q1 | $690K | Buy |
4,257
+210
| +5% | +$34K | 0.08% | 34 |
|
|
2021
Q4 | $548K | Buy |
+4,047
| New | +$548K | 0.06% | 66 |
|